RTX (RTX) Q4 23/24 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 23/24 earnings summary
21 Oct, 2025Executive summary
Revenue for 2023/24 was DKK 498 million, down from DKK 783 million the previous year, reflecting high customer inventory levels and lower demand, especially in Enterprise and ProAudio segments.
EBITDA dropped sharply to DKK 3 million (2022/23: DKK 108 million), and EBIT was negative at DKK -34 million (2022/23: DKK 68 million).
Net profit for the year was DKK -31 million, with EPS at DKK -3.8, compared to DKK 47 million and EPS of DKK 5.7 last year.
The company maintained a strong equity ratio of 65.8% and a net liquidity position of DKK 108 million.
No dividend will be distributed for 2023/24; a DKK 20 million share buyback was completed.
Financial highlights
Gross margin improved slightly to 46.7% (2022/23: 45.8%) despite lower revenue.
Cash flow from operations was DKK 21.5 million, down from DKK 97 million in 2022/23.
Total assets decreased to DKK 491 million (2022/23: DKK 578 million), mainly due to reductions in inventory, receivables, and cash.
Capitalized development costs increased to DKK 20 million, reflecting ongoing investment in new platforms and solutions.
Outlook and guidance
For 2024/25, revenue is expected in the range of DKK 490–520 million, with EBITDA between DKK 0–20 million and EBIT between DKK -35 to -15 million.
Macroeconomic and geopolitical uncertainty, as well as high customer inventory, continue to limit visibility and impact demand.
Long-term ambition of DKK 1 billion revenue and EBITDA margin above 16% remains, but timeline for achievement is now open-ended.
Latest events from RTX
- Revenue up 7% to DKK 108m, with strong Healthcare and ProAudio growth, margin up to 54.9%.RTX
Q1 25/262 Feb 2026 - Revenue up 7% year-over-year, gross margin and liquidity improved, guidance maintained.RTX
Q1 25/2629 Jan 2026 - Q3 revenue and margin improved, but outlook cut amid weak demand and short order cycles.RTX
Q3 23/2423 Jan 2026 - Revenue up 23% and gross margin at 51%, led by Enterprise; outlook limited by short order horizons.RTX
Q1 24/259 Jan 2026 - Revenue up 10%, gross margin at 50%-51%, EBITDA surged, and outlook remains strong.RTX
Q4 24/2529 Nov 2025 - Double-digit revenue growth and margin expansion achieved, with strong outlook for 2025/26.RTX
Q4 24/2529 Nov 2025 - Strong revenue and margin growth led to raised guidance and a DKK 20m share buyback.RTX
Q3 24/2523 Nov 2025 - Revenue up 23% and gross margin at 50.8%, but outlook limited by short order cycles.RTX
Q1 24/256 Jun 2025 - Enterprise and Healthcare growth drove strong H1 results, but tariff risks remain.RTX
Q2 24/255 Jun 2025